Assessment of Exercise Capacity in Patients Diagnosed with Moderate and Severe Bronchial Asthma: Preliminary Prospective Observational Study
Weronika Bajer,Marta Majewska-Pulsakowska,Małgorzata Paprocka-Borowicz,Krzysztof Wytrychowski,Jakub Taradaj,Kuba Ptaszkowski
DOI: https://doi.org/10.2147/jaa.s458717
2024-12-04
Journal of Asthma and Allergy
Abstract:Weronika Alicja Bajer, 1 Marta Majewska-Pulsakowska, 1 Ma&lstrokgorzata Paprocka-Borowicz, 1 Krzysztof Wytrychowski, 2 Jakub Taradaj, 3 Kuba Ptaszkowski 1 1 Faculty of Health Sciences, Department of Physiotherapy, Wroclaw Medical University, Wroclaw, Lower Silesian Voivodeship, Poland; 2 Faculty of Medicine, Clinical Department of Internal Medicine, Pneumology and Allergology, Wroclaw Medical University, Wroclaw, Lower Silesian Voivodeship, Poland; 3 Institute of Physiotherapy and Health Sciences, Academy of Physical Education in Katowice, Katowice, Silesian Voivodeship, Poland Correspondence: Weronika Alicja Bajer, Wroclaw Medical University, Cha&lstrokubi&nacuteskiego 3, 50-368 Wroc&lstrokaw, Wroclaw, Poland, Tel +48 71 784 28 15, Email Purpose: The main objective of the study was to assess exercise capacity and physical activity levels in patients with bronchial asthma compared to a control group without asthma, as well as to investigate how asthma severity affects the results of the 6MWT and physical activity as measured by the IPAQ questionnaire. Patients and Methods: A total of 63 individuals were studied, divided into two groups: Group A, consisting of 33 individuals with bronchial asthma, and Group B, consisting of 30 individuals from the general population without bronchial asthma. In both groups, the following assessments were performed: The Six-Minute Walk Test (6MWT), The International Physical Activity Questionnaire (IPAQ) and the Borg rating of perceived exertion scale (the Borg RPE scale) ABB. Results: It was demonstrated that patients with moderate asthma covered more distance during the 6MWT than patients diagnosed with severe asthma. The difference in metres covered between the two groups was statistically significant (p < 0.001), which could be observed during the walk test. The results indicate that a larger proportion of patients with asthma (76%) fall into the insufficient physical activity category compared to those without asthma (24%). Conversely, a higher percentage of non-asthmatic individuals (66.67%) report sufficient physical activity compared to asthmatic patients (33.33%)(P=0.005). Conclusion: This study demonstrated that asthma severity significantly impacts exercise capacity, as shown by shorter distances covered in the 6-minute walk test (6MWT) among patients with severe asthma. While overall physical activity levels (measured by the IPAQ) were not significantly different between asthma and non-asthma groups, asthma patients exhibited significantly more sitting time, suggesting a more sedentary lifestyle. Keywords: asthma, 6MWT, IPAQ According to the Global Strategy for Asthma Management and Prevention GINA 2022 (the GINA 2022 Report), bronchial asthma is a heterogeneous disease marked by chronic airway inflammation. The symptoms of this disease include wheezing, dyspnoea, chest tightness, and cough of variable frequency and severity. 1 The pathomechanism of bronchial asthma is primarily chronic airway inflammation. Numerous cells and the mediators they produce are involved in this process, resulting in characteristic pathophysiological and pathomorphological changes. The causes of asthma development are divided into two groups: those that cause the development of the disease and those that trigger its symptoms. These usually include individual factors (genetic predisposition) and environmental factors that emerge later in the course of the disease. The pathomechanisms responsible for the development and severity of asthma symptoms are complex and interact with each other. Individual factors include genetic factors, obesity and gender. Conversely, environmental factors include allergens, infections, occupational factors, tobacco smoke, outdoor and indoor air pollution, and diet. 2 Assessing the severity of bronchial asthma is a major step in the overall assessment of an asthmatic patient. According to previous GINA reports, it was recommended to analyse asthma severity before starting treatment. A previous assessment of asthma severity led to asthma being diagnosed as 'severe' before treatment. Pharmacotherapy and general recommendations usually lead to significant control of symptoms or complete resolution. 3 Hence, the GINA 2022 report recommends that asthma severity be assessed retrospectively based on the treatment required to control symptoms and exacerbations. Assessment can be performed after a few months of taking NSAIDs and when treatment has decreased over several months or years. The severity of the disease is not constant; it changes over months and years. According to GINA 2022 experts, there are three degrees of asthma severity: • mild -Abstract Truncated-
immunology,allergy,respiratory system